TM
Therapeutic Areas
SeaStar Medical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Quelimmune (SCD-Pediatric) | Pediatric Acute Kidney Injury (AKI) with Sepsis/Septic Condition | Approved |
| SCD-Adult | Adult Acute Kidney Injury (AKI) requiring CRRT | Pivotal Trial |
| SCD-Pediatric | Systemic Inflammatory Response in Cardiac Surgery (Pediatric) | Investigational |
Leadership Team at SeaStar Medical
ES
Eric Schlorff
Chief Executive Officer
MM
Michael Messinger
Chief Financial Officer
KC
Kevin Chung, M.D.
Chief Medical Officer
SP
Sai P. Iyer, Ph.D.
Senior Vice President, Medical Affairs & Research
TV
Tim Varacek
Senior Vice President, Commercial & Business Operations
HD
H. David Humes, M.D.
SCD Inventor & Scientific Advisor
AA
Ayse Akcan-Arikan, MD
Scientific Advisor
DA
David Askenazi, MD, MSPH
Scientific Advisor
SB
Sean Bagshaw, MD, MSc
Scientific Advisor